ATE315399T1 - Hemmung von systemischen infektionen in menschen und wirbeltieren mit ballaststoffen - Google Patents

Hemmung von systemischen infektionen in menschen und wirbeltieren mit ballaststoffen

Info

Publication number
ATE315399T1
ATE315399T1 AT01985674T AT01985674T ATE315399T1 AT E315399 T1 ATE315399 T1 AT E315399T1 AT 01985674 T AT01985674 T AT 01985674T AT 01985674 T AT01985674 T AT 01985674T AT E315399 T1 ATE315399 T1 AT E315399T1
Authority
AT
Austria
Prior art keywords
inhibition
systemic infections
fiber
human
dietary fiber
Prior art date
Application number
AT01985674T
Other languages
English (en)
Inventor
Randal K Buddington
Loo Jan Van
Anne Frippiat
Original Assignee
Univ Mississippi
Tiense Suikerraffinaderij Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24693153&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE315399(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Mississippi, Tiense Suikerraffinaderij Nv filed Critical Univ Mississippi
Application granted granted Critical
Publication of ATE315399T1 publication Critical patent/ATE315399T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21Addition of substantially indigestible substances, e.g. dietary fibres
    • A23L33/22Comminuted fibrous parts of plants, e.g. bagasse or pulp
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Fodder In General (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT01985674T 2000-09-28 2001-09-27 Hemmung von systemischen infektionen in menschen und wirbeltieren mit ballaststoffen ATE315399T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/671,106 US7431939B1 (en) 2000-09-28 2000-09-28 Inhibition of systemic infections in humans and vertebrates by dietary fibers

Publications (1)

Publication Number Publication Date
ATE315399T1 true ATE315399T1 (de) 2006-02-15

Family

ID=24693153

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01985674T ATE315399T1 (de) 2000-09-28 2001-09-27 Hemmung von systemischen infektionen in menschen und wirbeltieren mit ballaststoffen

Country Status (11)

Country Link
US (1) US7431939B1 (de)
EP (1) EP1320375B1 (de)
JP (1) JP4309650B2 (de)
CN (1) CN1315482C (de)
AT (1) ATE315399T1 (de)
CA (1) CA2423783C (de)
DE (1) DE60116662T2 (de)
DK (1) DK1320375T3 (de)
ES (1) ES2252317T3 (de)
NO (1) NO331751B1 (de)
WO (1) WO2002026242A2 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7431939B1 (en) 2000-09-28 2008-10-07 Mississippi State University Inhibition of systemic infections in humans and vertebrates by dietary fibers
US20040001898A1 (en) * 2002-06-26 2004-01-01 Armand Malnoe Compositions and methods for detoxification and cancer prevention
CA2633292C (en) 2005-12-16 2015-04-28 N.V. Nutricia Use of soluble dietary fibres against muscle wasting
US20100316769A1 (en) * 2006-03-29 2010-12-16 Gail Czarnecki-Maulden Dietary supplements containing probiotics
US20090061008A1 (en) * 2007-08-30 2009-03-05 Levy Mark M Fiber/granule complex for treatment of the gi tract
AR072141A1 (es) 2008-06-13 2010-08-11 Nutricia Nv Composicion nutricional para lactantes nacidos por cesarea
KR20130097090A (ko) * 2010-06-30 2013-09-02 네스텍 소시에테아노님 피부 색소침착의 조절을 위한 치커리산 및 유도체의 용도
US9655912B2 (en) 2012-02-16 2017-05-23 Akeso Biomedical, Inc. Reduction of gastrointestinal tract colonisation by campylobacter
WO2013187755A1 (en) 2012-06-14 2013-12-19 N.V. Nutricia Fermented infant formula with non digestible oligosaccharides
WO2016025448A2 (en) 2014-08-13 2016-02-18 Akeso Biomedical, Inc. Antimicrobial compounds and compositions, and uses thereof
CN104872457A (zh) * 2015-06-23 2015-09-02 通威股份有限公司 一种提高罗非鱼抗链球菌能力的配合饲料
RU2721257C2 (ru) * 2015-06-23 2020-05-18 Сосьете Де Продюи Нестле С.А. Питательные композиции и детские смеси, содержащие олигофруктозу, для снижения нагрузки патогенных бактерий в кишечнике младенцев и детей младшего возраста
US20190000873A1 (en) * 2015-08-04 2019-01-03 Südzucker AG Prophylactic use of inulin against sinusitis
US10653658B2 (en) 2015-08-11 2020-05-19 Akeso Biomedical, Inc. Biofilm inhibiting compositions enhancing weight gain in livestock
EP3334440B1 (de) 2015-08-11 2021-04-14 Akeso Biomedical, Inc. Biofilmhemmende zusammensetzungen zur verbesserung der gewichtszunahme bei nutztieren
CN105124248A (zh) * 2015-08-28 2015-12-09 通威股份有限公司 一种提高红罗非鱼抗病机能的配合饲料
EP3207933A1 (de) * 2016-02-17 2017-08-23 Proponent Biotech GmbH Verwendungen von polyfructanen
BE1025705B1 (fr) * 2017-09-12 2019-06-18 Cosucra Groupe Warcoing Sa Amélioration de la maladie et des conditions générales de la volaille et du bétail à l'aide d'une racine chicorée séchée
US10842811B2 (en) * 2018-02-28 2020-11-24 The Trustees Of Columbia University In The City Of New York Inulin for preventing antibiotic resistant infection and pathogen colonization

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987002679A1 (en) * 1985-10-31 1987-05-07 The Australian National University Immunotherapeutic treatment
US5032579A (en) 1987-10-13 1991-07-16 Coors Biotech, Inc. Method for inhibiting the growth of salmonella
AU651626B2 (en) 1990-10-24 1994-07-28 Nestec S.A. Medical foods having soluble fiber
ES2060543B1 (es) * 1993-03-26 1995-04-01 Cia Gral Del Algarrobo De Espa Fibra natural de algarroba y procedimiento para su obtencion.
DK0638589T3 (da) 1993-08-10 1998-09-21 Suedzucker Ag Inulinderivater, fremgangsmåde til deres fremstilling og deres anvendelse
US6001878A (en) 1994-01-11 1999-12-14 Van Leeuwen; Paulus Aloisius Marie Method of treating disorders of the animal or human body by administering amino acids
US6241983B1 (en) * 1994-10-28 2001-06-05 Metagenics, Inc. Bacteria-and fiber-containing composition for human gastrointestinal health
US5531989A (en) 1994-10-28 1996-07-02 Metagenics, Inc. Immunoglobulin and fiber-containing composition for human gastrointestinal health
EP0756828B2 (de) * 1995-08-04 2010-09-22 N.V. Nutricia Diätfasern enthaltende Nahrungszusammensetzung
EP0879600A1 (de) * 1997-05-20 1998-11-25 Tiense Suikerraffinaderij N.V. (Raffinerie Tirlemontoise S.A.) Fruktan-haltige Zusammensetzung zur Vorbeugung und Behandlung von Dickdarmkrebs
DK0887024T3 (da) 1997-06-23 2004-09-27 Nestle Sa Ernæringssammensætning omfattende ærtefibre og inulin
EP0904784A1 (de) 1997-09-22 1999-03-31 N.V. Nutricia Probiotisches Ernährungspräparat
US6248375B1 (en) * 2000-03-14 2001-06-19 Abbott Laboratories Diabetic nutritionals and method of using
US7431939B1 (en) 2000-09-28 2008-10-07 Mississippi State University Inhibition of systemic infections in humans and vertebrates by dietary fibers
EP1428528A1 (de) 2002-09-27 2004-06-16 Tiense Suikerraffinaderij N.V. Synergistische Zusammensetzungen aus Ballaststoffe und NSAID zur Behandlung von Krebs

Also Published As

Publication number Publication date
DE60116662D1 (de) 2006-04-06
CA2423783A1 (en) 2002-04-04
EP1320375B1 (de) 2006-01-11
CN1466460A (zh) 2004-01-07
JP4309650B2 (ja) 2009-08-05
NO20031259L (no) 2003-05-07
WO2002026242A2 (en) 2002-04-04
NO20031259D0 (no) 2003-03-19
EP1320375A2 (de) 2003-06-25
JP2004509922A (ja) 2004-04-02
US7431939B1 (en) 2008-10-07
DK1320375T3 (da) 2006-05-22
CN1315482C (zh) 2007-05-16
NO331751B1 (no) 2012-03-19
CA2423783C (en) 2007-11-20
DE60116662T2 (de) 2006-11-09
WO2002026242A3 (en) 2002-05-30
ES2252317T3 (es) 2006-05-16

Similar Documents

Publication Publication Date Title
ATE315399T1 (de) Hemmung von systemischen infektionen in menschen und wirbeltieren mit ballaststoffen
UA27848C2 (uk) Лікарська форма, що перорально вводиться, для лікування центральних станів дефіциту допаміну
BR0015188A (pt) Composições farmacêuticas
LU90987I2 (fr) Copaxone et ses dérivés pharmaceutiquement acceptables
HUP9802356A2 (hu) Foggondozó táplálék hobbi állatoknak
BR9706897A (pt) Composições antifúngicas com biodisponibilidade aperfeiçoada.
KR920702216A (ko) 아세틸 d-카르니틴의 녹내장 치료에의 용도
SE9800550D0 (sv) A pharmaceutical preparation comprising an angiotensin II type 2 receptor agonist, and use thereof
IT1282353B1 (it) Composizione farmaceutica, in particolare liquida, per sommanistrazione orale di ondansetron e metodi per la sua produzione
TR200100629T2 (tr) Mide-bağırsak aktif maddeleri içeren mukozaya yapışan oral bileşimler
CA2136404A1 (fr) Composition solide mucoadhesive, therapeutique ou hygienique, pour administration par application sur la muqueuse buccale ou nasale
JP2004509922A5 (de)
CO5190674A1 (es) Tratamiento de desordenes neuroticos desordenes neuroticos
ATE153374T1 (de) Lps-produzierende bakterien, lipopolysiccharide und lps enthaltende arzneimittel und tierärztliche medikamente
FI955837A (fi) Menetelmä suun kautta annettavan, kiinteän, diklofenaakkia sisältävän annostelumuodon valmistamiseksi
KR910016327A (ko) 호중구에 의한 엘라스타제 방출 저해제로서의 테니댑의 용도
KR960003718A (ko) 말초신경병 및 중추신경변성병의 치료에 유용한 의약의 제조를 위한 이펜프로딜 및 그 부분입체이성질체의 이용
KR920011469A (ko) 구강 조성물
BR0116373A (pt) Utilização de tienilciclo-hexilamina, produto, e, composições farmacêuticas
RU93016671A (ru) Иммуномодулятор
Bugorkova Comparative characterization of the pathogenic action of Vibrio cholerae of group non-O 1, serovar O 139, and group O 1 on the APUD system of the intestine of suckling rabbits
KR920016104A (ko) 노인성 특발적 백내장 약제 제조를 위한 칼시토닌의 국소적용 용도 및 이의 약제학적 조성물
KR960700053A (ko) 방사선회복제로서 리루졸의 이용(application of riluzole as a radiorestorer)
AU2001295839A1 (en) Use of agents active against candida in the treatment of disorders of the oral and intestinal mucosa
KR960010013A (ko) 진통약물과 생강추출처리물로 이루어진 진통효과 상승작용 조성물

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties